Hemalkumar B Mehta1, Shuang Li2, James S Goodwin2. 1. Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Electronic address: hbmehta@jhu.edu. 2. Sealy Center on Aging and Department of Internal Medicine, University of Texas Medical Branch, Galveston.
Abstract
OBJECTIVE: To determine the effectiveness of booster vaccinations on the risk of hospitalization with coronavirus disease 2019 (COVID-19) and how it varies by enrollee characteristics and interval from the initial vaccination to receipt of a booster. PATIENTS AND METHODS: This cohort study used 100% Medicare claims from January 1, 2020, through December 31, 2021, and matched 3,940,475 individuals who received boosters to 3,940,475 controls based on week and type of original COVID-19 vaccine and demographic and clinical characteristics. We compared the association of booster vs no booster with COVID-19 hospitalization using Cox proportional hazards regression models controlling for patient characteristics. We also determined the association of time from original vaccine to booster with COVID-19 hospitalization. RESULTS: Over a maximum of 130 days of follow-up, boosted enrollees had 8.20 (95% CI, 7.81 to 8.60) COVID-19 hospitalizations per million days vs 43.70 (95% CI, 42.79 to 44.64) for controls (81% effectiveness). Effectiveness varied by race, prior hospitalizations, and certain comorbidities, for example, leukemia/lymphoma (53% effectiveness), autoimmune disease (73%), and dementia (73%). Boosters received between 6 and 9 months after original vaccination varied between 81% and 85% effectiveness, while boosters received at 5 to 6 months (62%) or less than 5 months (58%) were less effective. CONCLUSION: Boosters are highly effective in the Medicare population. Approximately 69,225 hospitalizations would be prevented by boosters in the 15 million individuals aged 65 years or older currently not boosted in a period similar to the September 2020 through January 2021 period studied. Boosters provided the greatest benefits if they were received between 6 and 9 months following original vaccinations. However, boosters were associated with substantial decreases in COVID-19 hospitalizations in all categories of enrollees.
OBJECTIVE: To determine the effectiveness of booster vaccinations on the risk of hospitalization with coronavirus disease 2019 (COVID-19) and how it varies by enrollee characteristics and interval from the initial vaccination to receipt of a booster. PATIENTS AND METHODS: This cohort study used 100% Medicare claims from January 1, 2020, through December 31, 2021, and matched 3,940,475 individuals who received boosters to 3,940,475 controls based on week and type of original COVID-19 vaccine and demographic and clinical characteristics. We compared the association of booster vs no booster with COVID-19 hospitalization using Cox proportional hazards regression models controlling for patient characteristics. We also determined the association of time from original vaccine to booster with COVID-19 hospitalization. RESULTS: Over a maximum of 130 days of follow-up, boosted enrollees had 8.20 (95% CI, 7.81 to 8.60) COVID-19 hospitalizations per million days vs 43.70 (95% CI, 42.79 to 44.64) for controls (81% effectiveness). Effectiveness varied by race, prior hospitalizations, and certain comorbidities, for example, leukemia/lymphoma (53% effectiveness), autoimmune disease (73%), and dementia (73%). Boosters received between 6 and 9 months after original vaccination varied between 81% and 85% effectiveness, while boosters received at 5 to 6 months (62%) or less than 5 months (58%) were less effective. CONCLUSION: Boosters are highly effective in the Medicare population. Approximately 69,225 hospitalizations would be prevented by boosters in the 15 million individuals aged 65 years or older currently not boosted in a period similar to the September 2020 through January 2021 period studied. Boosters provided the greatest benefits if they were received between 6 and 9 months following original vaccinations. However, boosters were associated with substantial decreases in COVID-19 hospitalizations in all categories of enrollees.
Authors: Sameer S Kadri; Jake Gundrum; Sarah Warner; Zhun Cao; Ahmed Babiker; Michael Klompas; Ning Rosenthal Journal: JAMA Date: 2020-12-22 Impact factor: 56.272
Authors: James S Goodwin; Shuang Li; Jie Zhou; James E Graham; Amol Karmarkar; Kenneth Ottenbacher Journal: BMC Health Serv Res Date: 2017-05-30 Impact factor: 2.655
Authors: Sean L Wu; Andrew N Mertens; Yoshika S Crider; Anna Nguyen; Nolan N Pokpongkiat; Stephanie Djajadi; Anmol Seth; Michelle S Hsiang; John M Colford; Art Reingold; Benjamin F Arnold; Alan Hubbard; Jade Benjamin-Chung Journal: Nat Commun Date: 2020-09-09 Impact factor: 14.919
Authors: Hiam Chemaitelly; Patrick Tang; Mohammad R Hasan; Sawsan AlMukdad; Hadi M Yassine; Fatiha M Benslimane; Hebah A Al Khatib; Peter Coyle; Houssein H Ayoub; Zaina Al Kanaani; Einas Al Kuwari; Andrew Jeremijenko; Anvar H Kaleeckal; Ali N Latif; Riyazuddin M Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Mohamed G Al Kuwari; Hamad E Al Romaihi; Adeel A Butt; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini; Laith J Abu-Raddad Journal: N Engl J Med Date: 2021-10-06 Impact factor: 91.245
Authors: Mark G Thompson; Karthik Natarajan; Stephanie A Irving; Elizabeth A Rowley; Eric P Griggs; Manjusha Gaglani; Nicola P Klein; Shaun J Grannis; Malini B DeSilva; Edward Stenehjem; Sarah E Reese; Monica Dickerson; Allison L Naleway; Jungmi Han; Deepika Konatham; Charlene McEvoy; Suchitra Rao; Brian E Dixon; Kristin Dascomb; Ned Lewis; Matthew E Levy; Palak Patel; I-Chia Liao; Anupam B Kharbanda; Michelle A Barron; William F Fadel; Nancy Grisel; Kristin Goddard; Duck-Hye Yang; Mehiret H Wondimu; Kempapura Murthy; Nimish R Valvi; Julie Arndorfer; Bruce Fireman; Margaret M Dunne; Peter Embi; Eduardo Azziz-Baumgartner; Ousseny Zerbo; Catherine H Bozio; Sue Reynolds; Jill Ferdinands; Jeremiah Williams; Ruth Link-Gelles; Stephanie J Schrag; Jennifer R Verani; Sarah Ball; Toan C Ong Journal: MMWR Morb Mortal Wkly Rep Date: 2022-01-21 Impact factor: 35.301